Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis
about
Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritisImmunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetesUpdate on mesenchymal stem cell-based therapy in lupus and sclerodermaMesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesMesenchymal stem cells, autoimmunity and rheumatoid arthritisStromal cell-based immunotherapy in transplantationAcquiring chondrocyte phenotype from human mesenchymal stem cells under inflammatory conditionsMesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes MellitusHuman mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applicationsIntraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitisImmunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated AntigensMesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal modelsPI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune PolarizationClinical applications of mesenchymal stem cells in chronic diseases.Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.SOCS1 regulates the immune modulatory properties of mesenchymal stem cells by inhibiting nitric oxide production.Preclinical efficacy and mechanisms of mesenchymal stem cells in animal models of autoimmune diseases.Cotransfer of regulatory T cells improve the therapeutic effectiveness of mesenchymal stem cells in treating a colitis mouse modelPathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles.Stem cell paracrine actions and tissue regeneration.Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.Use of immune modulation by human adipose-derived mesenchymal stem cells to treat experimental arthritis in mice.Intra-articular injection of mesenchymal stem cells leads to reduced inflammation and cartilage damage in murine antigen-induced arthritisIL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritisUmbilical cord-derived mesenchymal stem cells regulate thymic epithelial cell development and function in Foxn1(-/-) mice.Human limbal fibroblast-like stem cells induce immune-tolerance in autoreactive T lymphocytes from female patients with Hashimoto's thyroiditis.Bone marrow-derived clonal mesenchymal stem cells inhibit ovalbumin-induced atopic dermatitis.Mesenchymal stem cells as a potent cell source for articular cartilage regeneration.Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantationAlterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritisAdipose-derived stem cells ameliorate allergic airway inflammation by inducing regulatory T cells in a mouse model of asthmaGimme shelter: the immune system during pregnancy.TNFα and IL-1β influence the differentiation and migration of murine MSCs independently of the NF-κB pathwayMesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.Human Bone Marrow Derived Mesenchymal Stem Cells Regulate Leukocyte-Endothelial Interactions and Activation of Transcription Factor NF-Kappa B.Mesenchymal stem cells as therapeutics and vehicles for gene and drug deliveryAutophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes.Local delivery of mesenchymal stem cells with poly-lactic-co-glycolic acid nano-fiber scaffold suppress arthritis in ratsIdentification of miR-27b as a novel signature from the mRNA profiles of adipose-derived mesenchymal stem cells involved in the tolerogenic response
P2860
Q24612869-4AE20E6B-FCD1-4494-BFDD-D0FDF2B624C0Q24644691-DF80E2F0-7AB8-47D4-BCCC-C732EECF7DF9Q26777402-8B551C54-10A5-4E4D-A7C8-ADC4F86781AEQ26799107-39D1B0D7-A627-4F82-B811-072D6AEC8D49Q26828950-6737E4D5-8406-4E8A-9B3C-D1524C5E7922Q26851908-4D43BD49-BAF4-4CB2-A7E1-74AE8478DD6EQ26852836-8D600E01-DDA3-4C33-A3EB-F53D0F0B6137Q26864580-95279DD5-9A02-41E2-8EE5-1A29F212D56EQ27004008-052055FC-BA2B-4C48-ACE5-9631C3EECADFQ27321287-C04AD155-4A5F-483F-BE4D-97720E425C93Q27489354-DD394FB0-E0BB-47E1-84B6-9545EB7804FBQ28085080-576D058C-8B62-4997-83AA-F2588AD8AC65Q28831131-23A0EE2B-BA11-4A72-A1C0-4D8DF0D0A17FQ30437823-DA6E8843-36FE-4EB7-AA4F-2774266493B4Q30660529-20440331-FA33-406E-B36F-C4FF05BBA209Q31161219-A02F594B-439D-49D1-8124-978ACC650D57Q33619017-0D85AAFA-B944-4B49-9F02-B3B6BEE61027Q33621594-34665A9D-7F1B-4A2B-9161-F836A857490EQ33625006-3581D8D5-38CE-47F5-85A9-EB685571B08BQ33708216-C7AABB28-E3A5-4F7B-AD15-D8FFCA39AEC6Q33719419-0F0C620F-D39E-4966-B48E-0AF967C54549Q33733295-AAAE51DC-0585-4567-BCD6-6565AD578580Q33740128-D4303258-8502-49BB-9854-070B189C8167Q33769303-AA3D4AA3-030B-4DB3-8E32-F60355619CCFQ33858279-C5490DBC-69CD-4301-961F-190C7C1BE2B2Q33868555-04443DC3-4E25-48E6-9BDD-4218F0575E45Q34007793-A41B7490-B1B6-41B8-82D3-0C658376F917Q34038859-9B338179-EA71-47ED-8F46-43057630CADEQ34097940-15AEDB0F-7AC7-44F8-BB94-623A96782AFEQ34153048-385A0221-B2B9-4B07-9041-22F9C7615226Q34162140-29D671B7-D613-4520-A995-75865E004671Q34177939-DE893173-82A7-4A97-A3F9-3CB1165FEC7BQ34255259-60258C37-F735-4FA5-83A5-D72530E8E38CQ34259085-FB5C2698-F4A8-4379-9DAA-2AD158B34BE5Q34306920-F287F670-A409-444B-A843-29477F9EB5AEQ34349428-E0FBEBD9-7A89-47CB-B42E-1D6D74F715A5Q34373132-CA7BFE88-2F28-4A45-A6E0-EB06C020C915Q34553368-35BC40ED-A4B9-4F19-ADF9-10A42B7CB584Q34634748-D84BA07D-C5FF-4A1A-A5E2-3F211CFA9669Q34683676-824D32AD-0785-4D76-BC31-916F3C0B8592
P2860
Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cell therapy using allogeneic ...... in collagen-induced arthritis
@ast
Cell therapy using allogeneic ...... in collagen-induced arthritis
@en
Cell therapy using allogeneic ...... in collagen-induced arthritis
@nl
type
label
Cell therapy using allogeneic ...... in collagen-induced arthritis
@ast
Cell therapy using allogeneic ...... in collagen-induced arthritis
@en
Cell therapy using allogeneic ...... in collagen-induced arthritis
@nl
prefLabel
Cell therapy using allogeneic ...... in collagen-induced arthritis
@ast
Cell therapy using allogeneic ...... in collagen-induced arthritis
@en
Cell therapy using allogeneic ...... in collagen-induced arthritis
@nl
P2093
P3181
P356
P1476
Cell therapy using allogeneic ...... in collagen-induced arthritis
@en
P2093
Andrea Augello
Giuseppina Pennesi
Ranieri Cancedda
Roberta Tasso
Simone Maria Negrini
P2860
P304
P3181
P356
10.1002/ART.22511
P407
P577
2007-04-01T00:00:00Z